ʻO kēia trailer no ke kiʻi paʻi Nā hōʻike o ka hōʻino hiʻohiʻona i kahi mea maʻi me MS e kūkākūkā ana i kona loulou i kāna hoʻopiha ʻana i ka mercury amalgam.

Multiple Sclerosis & Mercury Exposure; Hōʻuluʻulu Manaʻo

mercury niho a me nā sclerosis he nuiʻO ka sclerosis maha ("MS") ka mea i ʻike pinepine ʻia i ke kenekulia ʻumikūmāiwa i loko o ka manawa i hoʻohana pinepine ʻia ai nā hoʻopiha amalgam. Ua hōʻike ʻia nā hōʻike anecdotal ʻaʻole i paʻi ʻia he helu nui o, akā ʻaʻole naʻe nā mea a pau, nā mea i hōʻino ʻia me kā lākou mercury / kālā i hoʻopau i ka hoʻonā (remanist remission) a hoʻomaikaʻi maikaʻi paha. Ua kākoʻo ʻia kēia hōʻike anecdotal e nā noiʻi i paʻi ʻia i loko o nā makahiki he 50 i hala.

ʻO kahi laʻana, i ka hana i paʻi ʻia ma 1966, ua hoʻoholo ʻo Baasch he sclerosis nunui kahi ʻano mākua o ka acrodynia (maʻi ʻākala) a me kahi neuro-maʻi kūpili i hopena ʻia, i ka hapanui o nā hihia, e ka mercury mai nā hoʻopiha amalgam.1  Ua hōʻike ʻo Baasch i kekahi mau hihia kikoʻī a kuhikuhi i nā noiʻi e hoʻomau ana e hōʻike ana i ka pau ʻana o ka holomua a me ka hoʻomaikaʻi ʻana i ka hoʻonā ʻana o MS ma hope o ka hemo ʻana o nā hoʻopiha amalgam.

I loko o kahi noiʻi kikoʻī i paʻi ʻia ma 1978, ua hōʻike ʻo Craelius i kahi pilina paʻa (P <0.001) ma waena o nā helu make o MS a me nā caries niho.2  Ua hōʻike ka ʻikepili i ka hiki ʻole ke hiki i kēia hoʻopili ʻana ma muli o ka manawa wale. Ua kāpae ʻia nā kumu papaʻai he nui e hāʻawi i nā kumu.

ʻO kahi kuhiakau i hōʻike ʻia e TH Ingalls, MD, i ka makahiki 1983 i noi ʻia e kiʻi lohi, retrograde o ka mercury mai nā aʻa aʻa a i ʻole nā ​​hoʻopiha amalgam e alakaʻi iā MS i ka makahiki waena.3  Ua nānā hou ʻo ia i ka ʻikepili epidemiological ākea e hōʻike ana i ka hoʻopili lalani ma waena o nā helu make mai MS a me nā helu o nā niho pala, nalo, a piha hoʻi. I ka noiʻi i paʻi ʻia ma 1986, ua ʻōlelo ʻo Ingalls e nānā pono nā mea noiʻi i nā kumu o MS e nānā pono i nā moʻolelo niho o nā mea maʻi.4

Ua hoʻomau ʻia kahi mau noiʻi ʻē aʻe e hoʻokumu i ka pilina kūpono ma waena o MS a me mercury. ʻO kahi laʻana, noiʻi e Ahlrot-Westerlund mai 1987 ʻike ʻia he ʻewalu mau manawa o ka poʻe MS i ka pae maʻamau o ka mercury i loko o kā lākou cerebral spinal fluid ke hoʻohālikelike ʻia i nā kaohi olakino neurologically.5

Eia kekahi, ua ʻimi nā kānaka noiʻi ʻo Siblerud lāua ʻo Kienholz o ka Rocky Mountain Research Institute, Inc. i ke kuhiakau e pili ana ka mercury mai nā hoʻopiha amalgam niho i MS i ka hana i paʻi ʻia ma 1994.6  Hoʻohālikelike ia i nā hopena o ke koko ma waena o nā kumuhana MS i kāpae ʻia kā lākou amalgams a me nā poʻe MS me nā amalgams.

Ua loaʻa nā kumuhana MS me nā amalgams i nā pae haʻahaʻa o nā ʻulaʻula, nā hemoglobin, a me nā hematocrit i hoʻohālikelike ʻia me nā poʻe MS me ka hoʻoneʻe ʻana o amalgam. Ua hoʻohaʻahaʻa nui ʻia hoʻi nā pae thyroxine i ka hui amalgam MS, a he pae haʻahaʻa ko lākou o ka nui o nā Lymphocytes T a me nā hunaola suppressor T-8 (CD8). Loaʻa i ka hui amalgam MS ke kiʻekiʻe o ka nitrogen urea koko a me ka IgG serum haʻahaʻa. Ua ʻoi aku ke kiʻekiʻe o ka mercury lauoho ma nā kumuhana MS i hoʻohālikelike ʻia i ka pūʻulu mālama ʻole MS. Ua ʻike ʻia kahi nīnau nīnau olakino ua ʻoi aku ka nui o nā mea MS me amalgams (33.7%) ʻoi aku ka nui ma loko o nā mahina he 12 i hala i ka hoʻohālikelike ʻia me nā manawaleʻa MS me ka hoʻoneʻe ʻana o amalgam. 7

ʻO ke kuleana o ka myelin, kahi mea kōkua i ka lolo e hoʻouna i nā leka i ke kino, kahi mea nui o ka noiʻi MS, a ua hoʻokumu ka MELISA Foundation i ka mea a lākou e manaʻo nei he mea nui i ka hoʻomaopopo ʻana iā MS ma ka ʻike ʻana i ka loulou ma waena o nā mea āpau a me ka ʻaʻai. o myelin.  I ka noiʻi i paʻi ʻia ma 1999, Ua ʻōlelo ʻo Stejskal lāua ʻo Stejskal ua hoʻāla ʻia nā hopena hypersensitive e nā mea hao e komo ana i ke kino o ke kanaka āpau i ka metala i nīnau ʻia.8  Hoʻopili kēia mau mea i ka myelin, hoʻololi iki i kāna ʻano protein. I ka poʻe hypersensitive, ʻike hewa ʻia ke ʻano hou (myelin a me ka huna keleawe) ma ke ʻano he komo haole a hoʻouka ʻia (kahi pane autoimmune) ʻO ka lawehala ka "myelin plaques" i ka lolo, i maʻa mau i nā mea maʻi me MS. ʻO ia mau plake hiki ke hopena o ka allergy metala. Hoʻomaka koke ka MELISA Foundation e palapala i nā poʻe maʻi me nā pilikia autoimmunity e hana i kahi ʻāpana a, i kekahi mau hihia, hoʻōla piha ʻia e ka lawe ʻana i ke kumu o nā metala-pinepine ka hoʻopiha niho.9

ʻO kahi noiʻi cohort retrospective e Bates et al. i paʻi ʻia ma 2004 i loko o ka nānā ʻana i nā moʻolelo lapaʻau o 20,000 poʻe ma ka New Zealand Defense Force (NZDF).10  Ua manaʻo nā mea noiʻi e ʻimi i nā loulou kūpono ma waena o ka amalgam niho a me nā hopena olakino, a ʻo kā lākou mea i loaʻa ai i alakaʻi ʻia ai e hōʻike i kahi hui "ikaika" ma waena o MS a me ka hōʻike ʻana o amalgam niho. Eia kekahi, ʻekolu mau paʻi noiʻi hihia MS i paʻi ʻia ma mua i hoʻopaʻa ʻia ʻaʻohe hui nui me nā hoʻopiha mercury amalgam niho11 12 13 ʻike ʻia e Bates et al. e like me nā palena like ʻole. ʻOiai ʻoi aku ka kikoʻī, ua ʻōlelo ʻo Bates a me kāna mau hoa hana he hoʻokahi wale nō o ia mau noiʻi ʻekolu i hoʻohana i nā hihia hanana a me nā moʻolelo niho, a ua hana maoli ʻia ua hōʻike like nei i nā manaʻo loiloi kiʻekiʻe loa no ka nui o nā hoʻopiha mercury amalgam.14

Ua mālama ʻia kahi loiloi ʻōnaehana o nā puke e pili ana i ka amalgam niho a me nā sclerosis he nui e nā kānaka noiʻi Kanada a paʻi ʻia ma 2007.15  ʻOiai Aminzadeh et al. ua hōʻike i ka likiki o ka pilikia o MS ma waena o nā mea lawe amalgam i kūlike ʻole, ua ʻōlelo lākou he piʻi iki a me ka helu ʻole. Eia nō naʻe, ua ʻōlelo lākou i nā palena o kā lākou hana ponoʻī a ua paipai hoʻi i nā noiʻi e hiki mai ana e noʻonoʻo i nā kumu ʻē aʻe e like me ka nui o ka amalgam, ka ʻili o ka ʻili, a me ka lōʻihi o ka hōʻike ʻana ke nānā hou i kekahi loulou ma waena o ka amalgam niho a me MS.

He kanahikukumamāhā mau maʻi me MS a me kanahikukumamāhā mau mea manawaleʻa olakino nā kumuhana o kahi aʻo Iran e Attar et al. paʻi ʻia ma 2011.16  Ua ʻike nā kānaka noiʻi ua ʻoi aku ke kiʻekiʻe o ka pae mercury serum i nā maʻi MS ma mua o nā kaohi. Ua manaʻo lākou ʻo ka pae kiʻekiʻe o ka mercury i ke serum ke lilo i kumu i maʻalahi ʻia i nā sclerosis he nui.

I ka 2014, ʻo Roger Pamphlett o ke Kulanui o Sydney ma Australia ua loaʻa i kahi kuhiakau olakino i paʻi ʻia e pili ana i nā mea ʻona i pili i ke kaiapuni, e like me ka mercury, i nā maʻi o ka ʻōnaehana waena.17  Ma hope o ka wehewehe ʻana i ka hopena i nā lāʻau ʻona a me ka hopena o ke kino, ua noi ʻo ia: a me ka psychiatric (kaumaha nui a me nā maʻi bipolar) nā kūlana. "18

Ua hōʻike ʻia kahi noiʻi i paʻi ʻia ma 2016 i hōʻiliʻili ʻo Pamphlett i nā hōʻike e kākoʻo i kāna kuhiakau. Ua aʻo ʻo ia a me kekahi hoa hana i nā laʻana o ka iwi kuamoʻo mai 50 poʻe mai ka makahiki 1-95.19  Ua ʻike lākou he 33% o ka poʻe 61-95 mau makahiki i loaʻa nā metala kaumaha i loko o kā lākou interneurons ʻōiwi (ʻoiai ʻaʻole nā ​​makahiki ʻōpio). Ua alakaʻi ʻia ka noiʻi iā lākou e hoʻopau: "ʻO ka hōʻino ʻana i nā interneurons kaohi mai nā mea ʻawaʻawa i ke ola hope e hopena i ka hōʻeha excitotoxic i nā motoneuron a hiki i ke kumu o ka hōʻeha motoneuron a i ʻole nā ​​nalowale i nā ʻano e like me ALS / MND, sclerosis maha, sarcopenia a me nā pīpī pipiʻi."20

ʻO kekahi noi i paʻi ʻia ma 2016, mai nā mea noiʻi ma ke Kulanui o North Carolina, nā Centers for Disease Control and Prevent, a me ke Kulanui ʻo Duke, ua nānā pū kekahi i ka loulou kūpono ma waena o nā metala kaumaha a me nā sclerosis he nui.21  217 mau kānaka me MS a me 496 kāohi i hoʻokomo ʻia i loko o ka hoʻopaʻa hihia hihia hihia lehulehu, i hoʻolālā ʻia e loiloi i ka pilina ma waena o ka hopena i ke kēpau, mercury, a me nā mea hoʻoheheʻe a me 58 polymorphism nucleotide hoʻokahi i loko o nā genes pili i ka MS. Napier ma. ʻike ʻia he ʻoi aku ka nui o ka poʻe me MS ma mua o nā kaohi e hōʻike i ke alakaʻi a me ka mercury.

He mea nui nō hoʻi e hoʻomaopopo i ka nui o nā mōʻaukala hihia i paʻi ʻia i loko o nā makahiki he 25 i hala aku nei, me ka hoʻohui ʻia o kekahi o nā noiʻi i ʻōlelo ʻia ma luna, ua palapala i ka hiki no nā mea maʻi MS ke ʻike i nā pae like ʻole o ka hoʻomaikaʻi olakino ma hope o ka hemo ʻana o kā lākou hui ʻana i ka amalgam. Ua hōʻike ʻia nā noiʻi a Redhe a me Pleva i paʻi ʻia ma 1993 i ʻelua mau laʻana mai 100 mau hihia ahonui e loiloi ana i nā hopena pale maʻi o ka amalgam niho.22  Ua ʻōlelo lākou e hemo ka amalgam i nā hopena maikaʻi i kekahi mau hihia o MS. Ma kahi ʻano ʻē aʻe, ua aʻo ʻia e Huggins a me Levy i paʻi ʻia ma 1998 i hōʻike ʻia i ka hemo ʻana o nā amalgams niho, ke mālama ʻia me nā lāʻau lapaʻau ʻē aʻe, ua hoʻololi i nā ʻano photolabeling o nā protein fluid cerebrospinal i kēlā me kēia kanaka me MS.23

Hāʻawi kekahi mau hiʻohiʻona ʻē aʻe i nā hōʻike e pili ana i nā pono kūpono o ka hoʻoneʻe ʻana o amalgam i nā mea maʻi MS. Ua noiʻi ʻia mai ka MELISA Foundation i paʻi ʻia ma 2004 loiloi i nā hopena olakino o ka hoʻoneʻe ʻana o amalgam i nā mea mercury-maʻi me nā autoimmunity, a ʻo ka helu kiʻekiʻe loa o ka hoʻomaikaʻi i loaʻa i nā maʻi me MS.24  Hoʻohui ʻia, ua paʻi ʻia kahi moʻaukala hihia i ka makahiki 2013 mai nā mea noiʻi ʻItalia i kākau ʻia he mea hoʻomanawanui me MS i hoʻopau ʻia ka piha i ka mercury a laila ua hoʻomaikaʻi ʻia kahi chelation therapy (kahi ʻano detoxification) i hoʻomaikaʻi ʻia.25  ʻO nā kānaka noiʻi, ua pili kekahi o lākou me ka Ministry of Health i ʻItalia, ua kākau ʻo ia ka hōʻike i hōʻike ʻia e "hōʻoia i ke kuhiakau o TMP [lāʻau make mea ʻawaʻawa] ma ke ʻano he mea hoʻopuni kaiapuni a iatrogenic paha no MS, keu hoʻi ke waiho pono ʻole ka detoxification ma ka kumu. ” 26

ʻOiai ʻoi aku ka noiʻi e pono ai e hoʻoholo i ka piha o ka pilina ma waena o ka mercury a me MS, nā puke ʻepekema i paʻi ʻia i loko o nā makahiki he 50 i hala aku nei e hoʻomau nei e hōʻike i ka hōʻike ʻana o ka mercury mai nā amalgams niho, a me nā ʻano mercury haʻahaʻa haʻahaʻa ʻē aʻe. e noʻonoʻo koʻikoʻi no kahi kuleana i ka etiology o MS. Pono e hoʻomanaʻo ʻia he hana like nā hōʻike ʻona ʻē aʻe i kōkua i ka wehewehe ʻana i ke kumu o ka loaʻa ʻole o kahi mercury amalgam pani pani niho a kekahi mau mea maʻi MS paha. ʻO kahi laʻana, kahi noiʻi i paʻi ʻia ma 2016 e nā mea noiʻi ma Taiwan e hoʻopili iā MS e alakaʻi i ka lepo.27

He mea nui nō hoʻi e hoʻomanaʻo i ka laulā, ʻo ka noiʻi hou loa e hōʻike nei i ka nui o ka causation o MS he multifactorial. No laila, hiki ke nānā aku i ka mercury ma ke ʻano he hoʻokahi wale nō mea i loko o kēia maʻi, a me nā hōʻike ʻino ʻē aʻe, nā ʻano genetika, ke kū ʻana o nā maʻi ʻākela, a me kekahi mau hanana hou aʻe i hoʻokau i ke kuleana ma MS pū kekahi.

E hoʻomaopopo '

  1. ʻO Baasch E. Theoretische Überlegungen zur Ätiologie der Sclerosis multiplex. ʻO Schweiz. Arch. Neurol. Neurochir. Psychiat. 1966; 98: 1-9.
  2. ʻO Craelius W. Hoʻohālikelike epidemiology o nā sclerosis a me nā caries niho. Ka Nūpepa o Epidemiology a me ke olakino kaiāulu. 1978 Sep 1; 32 (3): 155-65.
  3. ʻO Ingalls TH. Epidemiology, etiology, a me ka pale ʻana i nā sclerosis maha: Ke kuhiakau a me ka ʻoiaʻiʻo. ʻO ka American Journal of Forensic Medicine and Pathology. ^ E Ha yM. 1983 Mar 1; 4 (1): 55-62.
  4. ʻO Ingalls T. Triggers no nā sclerosis he nui. ʻO ka Lancet. 1986 Jul 19; 328 (8499): 160.
  5. Ahlrot-Westerlund B. Multiple Sclerosis a me ka mercury i ka wai cerebrospinal. I loko o ʻO ka lua o ka Nordic Symposium ma nā Trace E Element a me ke olakino kanaka, Odense, Denmark 1987 ʻAuk.
  6. ʻO Siblerud RL, Kienholz E. ʻO nā hōʻike i ka mercury mai ka hoʻopiha ʻana i nā niho kālā kahi mea etilological paha i nā sclerosis he nui. ʻEpekema o ka nui o ke kaiapuni. ^ E Ha yM. 1994 Mar 15; 142 (3): 191-205.
  7. ʻO Siblerud RL, Kienholz E. ʻO nā hōʻike i ka mercury mai ka hoʻopiha ʻana i nā niho kālā kahi mea etilological paha i nā sclerosis he nui. ʻEpekema o ka nui o ke kaiapuni. ^ E Ha yM. 1994 Mar 15; 142 (3): 191-205.
  8. ʻO Stejskal J, ʻo Stejskal VD. Ke kuleana o nā metala i ka autoimmunity a me ka loulou i ka neuroendocrinology. Nā Palapala Neuroendocrinology. 1999;20(6):351-66.
  9. ʻO Stejskal VD, Danersund A, Lindvall A, Hudecek R, Nordman V, Yaqob A, Mayer W, Bieger W, Lindh U. ʻO nā lymphocytes kikoʻī kikoʻī: nā biomarkers o ka noʻonoʻo i ke kāne. Nā Palapala Neuroendocrinology. 1999; 20: 289-98.
  10. ʻO Bates MN, Fawcett J, Garrett N, Cutress T, Kjellstrom T. Nā hopena olakino o ka hoʻolauna amalgam niho: kahi noiʻi cohort retrospective. International Journal of Epidemiology. 2004 Aug 1; 33 (4): 894-902.
  11. Bangsi D, Ghadirian P, Ducic S, Morisset R, Ciccocioppo S, McMullen E, Krewski D. Dental amalgam a me nā sclerosis he nui: kahi noiʻi hoʻokolokolo hihia ma Montreal, Kanada. International Journal of Epidemiology. 1998 Aug 1; 27 (4): 667-71.
  12. Casetta I, Invernizzi M, Granieri E. Multiple sclerosis a me nā niho amalgam: kahi hoʻopaʻa hihia hihia ma Ferrara, ʻItalia. Neuroepidemiology. 2001 Mei 9; 20 (2): 134-7.
  13. McGrother CW, Dugmore C, Phillips MJ, Raymond NT, Garrick P, Baird WO. ʻO nā sclerosis he nui, nā caries niho a me nā hoʻopihapiha: kahi hoʻopaʻa ʻana i ka hihia. Ka Nūpepa Niho Pelekane. 1999 Sep 11; 187 (5): 261-4.
  14. Kāhea ʻia ʻo Bangsi D, Ghadirian P, Ducic S, Morisset R, Ciccocioppo S, McMullen E, Krewski D. Dental amalgam a me nā sclerosis he nui: kahi noiʻi hoʻokolokolo hihia ma Montreal, Kanada. International Journal of Epidemiology. 1998 Aug 1; 27 (4): 667-71.

Ma Bates MN, Fawcett J, Garrett N, Cutress T, Kjellstrom T. Nā hopena olakino o ka hoʻolauna amalgam niho: kahi noiʻi cohort retrospective. International Journal of Epidemiology. 2004 Aug 1; 33 (4): 894-902.

  1. Aminzadeh KK, Etminan M. Dental amalgam a me nā sclerosis he nui: He loiloi ʻōnaehana a me ka meta-analysis. Ka Nūpepa o Dentistry Health Public. 2007 Ian 1; 67 (1): 64-6.
  2. ʻO Attar AM, Kharkhaneh A, Etemadifar M, Keyhanian K, Davoudi V, Saadatnia M. Serum mercury pae a me nā sclerosis he nui. ʻImi ʻImi ʻImi Biology. ^ E Ha yM. 2012 Mei 1; 146 (2): 150-3.
  3. ʻO Pamphlett R. Uptake o nā mea ʻona kūlohelohe e ka locus ceruleus: kahi mea hiki ke hoʻokumu ʻia no nā neurodegenerative, demyelinating and psychiatric disorders. Nā maʻi Kauka Hypotheses. 2014 Ian 31; 82 (1): 97-104.
  4. ʻO Pamphlett R. Uptake o nā mea ʻona kūlohelohe e ka locus ceruleus: kahi mea hiki ke hoʻokumu ʻia no nā neurodegenerative, demyelinating and psychiatric disorders. Nā maʻi Kauka Hypotheses. 2014 Ian 31; 82 (1): 97-104.
  5. Pamphlett R, Iudaio SK. Uptake e pili ana i nā makahiki o nā metala kaumaha i nā interneurons iwi kanaka. ʻO Ke Aloha PloS. 2016 Sep 9; 11 (9): e0162260.
  6. Pamphlett R, Iudaio SK. Uptake e pili ana i nā makahiki o nā metala kaumaha i nā interneurons iwi kanaka. ʻO Ke Aloha PloS. 2016 Sep 9; 11 (9): e0162260.
  7. Napier MD, Poole C, Satten GA, Ashley-Koch A, Marrie RA, Williamson DM. Nā metala kaumaha, nā mea hiki ke hoʻoheheʻe ʻia, a me nā sclerosis he nui: Nānā makaʻāina i nā pilina o ke kaona. Waihona Palapala Kahiko o ke Kaiāulu. 2016 Ian 2; 71 (1): 26-34.
  8. ʻO Redhe ʻO, ʻo Pleva J. Hoʻōla hou ʻia mai ka amyotrophic lateral sclerosis a mai ka maʻi āpau ma hope o ka hemo ʻana o nā hoʻopiha amalgam niho. Ka Nūpepa International o ka pilikia a me ka palekana i ka lāʻau lapaʻau. 1993 Dec;4(3):229-36.
  9. ʻO Huggins HA, ʻo Levy TE. Hoʻololi ka Cerebrospinal fluid protein protein i nā sclerosis he nui ma hope o ka hemo ʻana o ka amalgam niho. Nānā ʻ Medicinelelo Hou. 1998 ʻAuk; 3: 295-300.
  10. ʻO Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VD. ʻO ka hopena maikaʻi o ka pani amalgam i ke olakino i nā maʻi me ka autoimmunity. Nā Palapala Neuroendocrinology. ^ E Ha yM. 2004 Jun 1; 25 (3): 211-8.
  11. Zanella SG, di Sarsina PR. ʻO ka pilikino ʻana i nā hoʻoponopono sclerosis he nui: e hoʻohana ana i ka chelapy therapy disk. Mākaʻikaʻi: Ka Pai no ka ʻEpekema a me Healing. 2013 Aug 31; 9 (4): 244-8.
  12. Zanella SG, di Sarsina PR. ʻO ka pilikino ʻana i nā hoʻoponopono sclerosis he nui: e hoʻohana ana i ka chelapy therapy disk. Mākaʻikaʻi: Ka Pai no ka ʻEpekema a me Healing. 2013 Aug 31; 9 (4): 244-8.
  13. ʻO Tsai CP, ʻo Lee CT. ʻO nā hanana sclerosis he nui e pili ana i ka lepo lepo a me nā arsenic concentrations ma Taiwan. ʻO Ke Aloha PloS. 2013 Jun 17; 8 (6): e65911.

Loaʻa i ka IAOMT kekahi mau kumuwaiwai hou aʻe e pili ana i kēia kumuhana.

Nā Mea kākau ʻatikala ʻo Mercury niho

( Kumu, Mea Hana Kiʻiʻoniʻoni, Philanthropist )

Ua hoʻomaʻamaʻa ʻo Kauka David Kennedy i ka niho niho no nā makahiki he 30 a ua haʻalele ʻo ia mai ka hana lapaʻau ma 2000. ʻO ia ka Pelekikena mua o ka IAOMT a ua aʻo ʻo ia i nā kauka niho a me nā ʻoihana olakino ʻē aʻe a puni ka honua e pili ana i nā kumuhana o ke olakino niho preventive, mercury toxicity, a me ka fluoride. Ua ʻike ʻia ʻo Kauka Kennedy ma ke ao holoʻokoʻa ma ke ʻano he kākoʻo no ka wai inu palekana, lāʻau lapaʻau olaola a he alakaʻi i ʻike ʻia ma ke kahua o ka mālama niho pale. ʻO Kauka Kennedy ka mea kākau a me ke alakaʻi o ka kiʻiʻoniʻoni palapala lanakila lanakila ʻo Fluoridegate.

Ua loaʻa iā Dr. Griffin Cole, MIAOMT kāna Mastership ma ka International Academy of Oral Medicine and Toxicology i ka makahiki 2013 a ua kākau ʻo ia i ka Brochure Fluoridation a ka Academy a me ka manaʻo ʻepekema ʻepekema ma ka hoʻohana ʻana i ka Ozone i ka lāʻau aʻa. He Pelekikena mua ʻo ia o ka IAOMT a lawelawe ʻo ia ma ka Papa Hoʻokele, ke Kōmike Mentor, ke Kōmike Fluoride, ke Kōmike Kūkākūkā a ʻo ia ka Luna Hoʻokele Fundamentals Course.

ʻO ka mea maʻi ma ka moena me ke kauka e kūkākūkā nei i nā hopena a me nā hopena ʻaoʻao ma muli o ka mercury toxicity
Ka hoʻopiha ʻana i ka Mercury: Nā ʻaoʻao a me nā hopena ʻo Dental Amalgam

Hoʻokumu ʻia nā hopena a me nā hopena ʻino o ka hoʻopiha ʻana o ka mercury amalgam mercury i nā helu pilikia pākahi.

ʻO Mercury Poisoning Symptoms a me nā niho hoʻopiha Amalgam

Hoʻokuʻu hoʻomau nā kinona amalgam mercury i ka mahu a hiki ke hana i kahi hōʻailona o nā hōʻailona ʻawahia mercury.

ʻO kahi loiloi piha o nā hopena o ka Mercury i nā hoʻopiha Amalgam kahua niho

Aia kēia loiloi 26 ʻaoʻao mai ka IAOMT e pili ana i ka noiʻi e pili ana i nā pilikia i ke olakino a me ke kaiapuni kanaka mai ka mercury i nā hoʻopiha amalgam niho.

Kaʻana i kēia ʻatikala ma ka pāpili kaiaulu